TM4SF5 and neoplasm: Compared with the control CPP, which did not block tumor formation driven by SNU449Tp cell injection, CPP containing the TM4SF5 C-terminal sequence inhibited tumor formation in a dose-dependent manner without any body weight loss (Figure 7A).